Brad is a confident and motivated commercial leader driven to build accountable and positive cultures with both internal and external partners to consistently deliver business results, achieve customer goals, and make a difference for patients utilizing his diverse experience spanning the biotech, pharmaceutical, molecular diagnostics, liquid biopsy, digital pathology, AI, and oncology healthcare sectors.